收藏切换
Advances in the study of mechanism of thrombolysis-induced hemorrhagic transformation and therapeutic drugs
收藏切换
PDF
Ling-lei KONG1, Yin-zhong MA2, Li LI1, Yan-xia CHEN3, Guan-hua DU1, *
Acta Pharmaceutica Sinica | 2018, 53(9) : 1467 - 1476
Less
收藏切换
Acta Pharmaceutica Sinica | 2018, 53(9): 1467-1476
REVIEWS
Advances in the study of mechanism of thrombolysis-induced hemorrhagic transformation and therapeutic drugs
Full
Ling-lei KONG1, Yin-zhong MA2, Li LI1, Yan-xia CHEN3, Guan-hua DU1, *
Affiliations
  • 1. Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
  • 3. BaoTou Medical College, Baotou 014060, China
Published: 2018-09-15 doi: 10.16438/j.0513-4870.2018-0296
Outline
收藏切换

Hemorrhagic transformation (HT) is a common complication of ischemic stroke, especially after thrombolytic therapy, which is associated with increased morbidity and mortality. Thrombolysis with tissue plasminogen activator (t-PA) increases the rate of HT by as much as 10-fold, and the mortality by about 60%. The patients who are eligible for t-PA treatment are still between 3.4% and 5.2% of all patients with acute ischemic stroke because of the narrow therapeutic time window. Due to the unknown mechanism and therapeutic target of HT, there are no effective drugs to decrease the incidence of HT. The main mechanism of HT is disruption of the blood-brain barrier (BBB) integrity and neurovascular homeostasis, involving a variety of molecular signaling pathways. In animal and clinical studies, combining therapeutic agents with t-PA, which may help to minimize BBB perturbations, reduces the incidence of HT and increases the safety of thrombolytic therapy. This article is prepared to review the mechanisms, targets and therapeutic drugs of t-PA induced HT in recent years to provide a reference to the basic research and drug development of HT.

stroke  /  hemorrhagic transformation  /  tissue plasminogen activator  /  blood-brain barrier
Ling-lei KONG, Yin-zhong MA, Li LI, Yan-xia CHEN, Guan-hua DU. Advances in the study of mechanism of thrombolysis-induced hemorrhagic transformation and therapeutic drugs[J]. Acta Pharmaceutica Sinica, 2018 , 53 (9) : 1467 -1476 . DOI: 10.16438/j.0513-4870.2018-0296
Year 2018 volume 53 Issue 9
PDF
118
51
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2018-0296
  • Receive Date:2018-04-03
  • Online Date:2026-01-15
  • Published:2018-09-15
Article Data
Affiliations
History
  • Received:2018-04-03
  • Revised:2018-04-24
Funding
Affiliations
    1. Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
    3. BaoTou Medical College, Baotou 014060, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2018-0296
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT